SUFLAVE

POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, AND SODIUM CHLORIDE FOR ORAL SOLUTION · Braintree Laboratories, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SUFLAVE, covering 2023-06-15 to 2023-06-15. Get the full timeline:

Most recent: FDA Approved: SUFLAVE — Original Application (Braintree Laboratories, Inc.)